By targeting the pericyte antigen DLK1, αDC1 vaccination led to significant changes in colon cancer vascular density, marked overall by reduced pericyte (PDGFR-beta and DLK1) and endothelial cell (CD31 and VEGFR2) markers. This evidence concerns the gene PECAM1 and malignant colon neoplasm.